Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Gone Caving: Roles of the Transcriptional Regulators YAP and TAZ in Skeletal Development

Kegelman CD., Collins JM., Nijsure MP., Eastburn EA., Boerckel JD.

Narrative Review on Cartilage Damage, published in Curr Osteoporos Rep (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Curr Osteoporos Rep (2020)
Reported sample size
—
Source database
Europe PMC
PMID
32712794
PMCID
PMC8040027
DOI
10.1007/s11914-020-00605-3
Citations
32

Abstract (original English)

Purpose of review The development of the skeleton is controlled by cellular decisions determined by the coordinated activation of multiple transcription factors. Recent evidence suggests that the transcriptional regulator proteins, Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ), could have important roles in directing the activity of these transcriptional programs. However, in vitro evidence for the roles of YAP and TAZ in skeletal cells has been hopelessly contradictory. The goals of this review are to provide a cross-sectional view on the state of the field and to synthesize the available data toward a unified perspective. Recent findings YAP and TAZ are regulated by diverse upstream signals and interact downstream with multiple transcription factors involved in skeletal development, positioning YAP and TAZ as important signal integration nodes in an hourglass-shaped signaling pathway. Here, we provide a survey of putative transcriptional co-effectors for YAP and TAZ in skeletal cells. Synthesizing the in vitro data, we conclude that TAZ is consistently pro-osteogenic in function, while YAP can exhibit either pro- or anti-osteogenic activity depending on cell type and context. Synthesizing the in vivo data, we conclude that YAP and TAZ combinatorially promote developmental bone formation, bone matrix homeostasis, and endochondral fr

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Bone MatrixHumansIntracellular Signaling Peptides and ProteinsAdaptor Proteins, Signal TransducingTranscription FactorsFracture HealingGene Expression Regulation, DevelopmentalBone DevelopmentHomeostasisYAP-Signaling Proteins

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research